about
Protura of Italy, with a key to species and their distributionIncidence and risk factors for liver enzyme elevation during highly active antiretroviral therapy in HIV-HCV co-infected patients: results from the Italian EPOKA-MASTER CohortVirological Mechanisms in the Coinfection between HIV and HCVComparison of HIV-1 genotypic resistance test interpretation systems in predicting virological outcomes over timeIncreasing clinical virulence in two decades of the Italian HIV epidemicTherapeutic immunization with HIV-1 Tat reduces immune activation and loss of regulatory T-cells and improves immune function in subjects on HAARTRisk factors and outcomes for late presentation for HIV-positive persons in Europe: results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE)Risk of Chronic Kidney Disease among Patients Developing Mild Renal Impairment during Tenofovir-Containing Antiretroviral TreatmentHIV-1 fitness landscape models for indinavir treatment pressure using observed evolution in longitudinal sequence data are predictive for treatment failure.RegaDB: community-driven data management and analysis for infectious diseases
P50
Q21192059-1D99C66B-6C73-4A86-898B-16FB09982FB8Q24814420-F75E67AF-8E8B-45D4-9F9B-76D49886925FQ26780313-447F83AB-1E0E-4E95-8204-2024523D2530Q28474806-DEE56FF2-C0AE-4D7A-9AC7-05567FD358E5Q28475522-73E2D3A7-D843-4355-8E3F-B487FDA4DD08Q28476094-CE71F70D-2FF4-404D-ABF0-D46D50F5048EQ28534394-3B593354-E847-4438-8BEF-3522DF03B102Q28554081-91DC6EBD-D97D-46F1-BDD9-B47167DED5A0Q30605804-A3A0519B-A1F5-4424-8EC0-A60BC223A4A0Q30621161-610393B4-8485-4CB9-812E-B41B4E236467
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Carlo Torti
@ast
Carlo Torti
@en
Carlo Torti
@es
Carlo Torti
@nl
Carlo Torti
@sl
type
label
Carlo Torti
@ast
Carlo Torti
@en
Carlo Torti
@es
Carlo Torti
@nl
Carlo Torti
@sl
prefLabel
Carlo Torti
@ast
Carlo Torti
@en
Carlo Torti
@es
Carlo Torti
@nl
Carlo Torti
@sl